Evidence map›Paper›PMID 29449336›Full record

ReviewArteriosclerosis, thrombosis, and vascular biology2018

Dual Anticoagulant and Antiplatelet Therapy for Coronary Artery Disease and Peripheral Artery Disease Patients.

Nigel Mackman, Henri M H Spronk, George A Stouffer, Hugo Ten Cate

Open access · greenAbstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in Arteriosclerosis, thrombosis, and vascular biology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
1.7field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 25 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Platelet-Neutrophil Crosstalk in Thrombosis.International journal of molecular sciences · 2023
    Review
  6. Review
  7. Saccharides fromExperimental and therapeutic medicine · 2022
    Article
  8. Article
  9. Article
  10. Article
  11. Protease Activity in Vascular Disease.Arteriosclerosis, thrombosis, and vascular biology · 2019
    Review
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 2 countries.

Nigel MackmanFrom the Thrombosis and Hemostasis Program, Division of Hematology and Oncology (N.M.) and Division of Cardiology (G.A.S.), Department of Medicine, McAllister Heart Institute, University of North Carolina at Chapel Hill; and Laboratory for Clinical Thrombosis and Haemostasis, Thrombosis Expert Centre, Department of Internal Medicine (H.M.H.S., H.t.C.) and Department of Biochemistry (H.M.H.S., H.t.C.), Cardiovascular School of Medicine (Cardiovascular Research Institute Maastricht), Maastricht University Medical Centre, the Netherlands. nmackman@med.unc.edu.
Henri M H SpronkFrom the Thrombosis and Hemostasis Program, Division of Hematology and Oncology (N.M.) and Division of Cardiology (G.A.S.), Department of Medicine, McAllister Heart Institute, University of North Carolina at Chapel Hill; and Laboratory for Clinical Thrombosis and Haemostasis, Thrombosis Expert Centre, Department of Internal Medicine (H.M.H.S., H.t.C.) and Department of Biochemistry (H.M.H.S., H.t.C.), Cardiovascular School of Medicine (Cardiovascular Research Institute Maastricht), Maastricht University Medical Centre, the Netherlands.
George A StoufferFrom the Thrombosis and Hemostasis Program, Division of Hematology and Oncology (N.M.) and Division of Cardiology (G.A.S.), Department of Medicine, McAllister Heart Institute, University of North Carolina at Chapel Hill; and Laboratory for Clinical Thrombosis and Haemostasis, Thrombosis Expert Centre, Department of Internal Medicine (H.M.H.S., H.t.C.) and Department of Biochemistry (H.M.H.S., H.t.C.), Cardiovascular School of Medicine (Cardiovascular Research Institute Maastricht), Maastricht University Medical Centre, the Netherlands.
Hugo Ten CateFrom the Thrombosis and Hemostasis Program, Division of Hematology and Oncology (N.M.) and Division of Cardiology (G.A.S.), Department of Medicine, McAllister Heart Institute, University of North Carolina at Chapel Hill; and Laboratory for Clinical Thrombosis and Haemostasis, Thrombosis Expert Centre, Department of Internal Medicine (H.M.H.S., H.t.C.) and Department of Biochemistry (H.M.H.S., H.t.C.), Cardiovascular School of Medicine (Cardiovascular Research Institute Maastricht), Maastricht University Medical Centre, the Netherlands.
Maastricht University Medical Centre · NL

Funding

TISSUE FACTOR GENE REGULATION IN MONOCYTESR01HL048872 · NHLBI · UNIV OF NORTH CAROLINA CHAPEL HILL · PI MACKMAN, NIGEL · 1992 to 2009
$2.9M
NHLBI NIH HHS R01 HL048872
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

AnticoagulantsBlood CoagulationBlood PlateletsClinical Decision-MakingCoronary Artery DiseaseHemorrhageHumansPatient SelectionPeripheral Arterial DiseasePlatelet ActivationPlatelet Aggregation InhibitorsRisk FactorsTime FactorsTreatment OutcomeAnticoagulantsPlatelet Aggregation Inhibitorsanticoagulantsapolipoproteincoronary artery diseasemyocardial infarctionpatients

Identifiers

PMID29449336
PMCPMC5978740
OpenAlexW2788517667

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.